NUDT15 R139C Variants Increase the Risk of Azathioprine-Induced Leukopenia in Chinese Autoimmune Patients

被引:20
作者
Fei, Xiang [1 ,2 ]
Shu, Qing [1 ]
Zhu, Huaijun [1 ]
Hua, Bingzhu [3 ]
Wang, Shiying [3 ]
Guo, Ling [4 ]
Fang, Yun [1 ]
Ge, Weihong [1 ]
机构
[1] Nanjing Drum Tower Hosp, Dept Pharm, Nanjing, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Drum Tower Hosp, Dept Rheumatol & Immunol, Nanjing, Jiangsu, Peoples R China
[4] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Nanjing, Jiangsu, Peoples R China
关键词
azathioprine; NUDT15; R139C; leukopenia; Chinese; autoimmune patients; INFLAMMATORY-BOWEL-DISEASE; THIOPURINE S-METHYLTRANSFERASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; METABOLITE MEASUREMENT; CLINICAL-SIGNIFICANCE; MAINTENANCE THERAPY; GENE POLYMORPHISMS; JAPANESE PATIENTS; KOREAN PATIENTS; CROHNS-DISEASE;
D O I
10.3389/fphar.2018.00460
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to investigate the influence of NUDT15 R139C, thiopurine S-methyltransferase (TPMT), and 6-TGN on azathioprine (AZA) induced leukopenia in Chinese autoimmune patients. Among 87 enrolled patients, 23 (26.4%) had leukopenia. The NUDT15 R139C variant was associated with leukopenia (p = 1.86 x 10(-7); OR: 7.59; 95% CI: 3.16-18.21). However, TPMT genotype was not shown to be correlated with the incidence of leukopenia (p = 0.95). There was no significant difference of 6-TGN concentration between patients with or without leukopenia (p = 0.15) and no association was found in patients with NUDT15 R139C variants alleles (p = 0.62). Finally, we found that the range of 6-TGN concentrations in autoimmune diseases was much lower than the established 6-TGN monitoring range for inflammatory bowel diseases. Therefore, the variant of NUDT15 R139C is strongly associated with AZA-induced leukopenia in Chinese patients with various autoimmune diseases such as systemic lupus erythematosus, Sjogren's syndrome, etc.
引用
收藏
页数:8
相关论文
共 51 条
[1]   Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease [J].
Ansari, A. ;
Arenas, M. ;
Greenfield, S. M. ;
Morris, D. ;
Lindsay, J. ;
Gilshenan, K. ;
Smith, M. ;
Lewis, C. ;
Marinaki, A. ;
Duley, J. ;
Sanderson, J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (08) :973-983
[2]   Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine [J].
Armstrong, L. ;
Sharif, J. -A. ;
Galloway, P. ;
McGrogan, P. ;
Bishop, J. ;
Russell, R. K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (09) :1106-1114
[3]   NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease [J].
Asada, Ayumi ;
Nishida, Atsushi ;
Shioya, Makoto ;
Imaeda, Hirotsugu ;
Inatomi, Osamu ;
Bamba, Shigeki ;
Kito, Katsuyuki ;
Sugimoto, Mitsushige ;
Andoh, Akira .
JOURNAL OF GASTROENTEROLOGY, 2016, 51 (01) :22-29
[4]   Analysis of Thiopurine S-Methyltransferase Genotypes in Japanese Patients with Inflammatory Bowel Disease [J].
Ban, Hiromitsu ;
Andoh, Akira ;
Tanaka, Aiko ;
Tsujikawa, Tomoyuki ;
Sasaki, Masaya ;
Saito, Yasuharu ;
Fujiyama, Yoshihide .
INTERNAL MEDICINE, 2008, 47 (19) :1645-1648
[5]   EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics [J].
Bertsias, G. ;
Ioannidis, J. P. A. ;
Boletis, J. ;
Bombardieri, S. ;
Cervera, R. ;
Dostal, C. ;
Font, J. ;
Gilboe, I. M. ;
Houssiau, F. ;
Huizinga, T. ;
Isenberg, D. ;
Kallenberg, C. G. M. ;
Khamashta, M. ;
Piette, J. C. ;
Schneider, M. ;
Smolen, J. ;
Sturfelt, G. ;
Tincani, A. ;
van Vollenhoven, R. ;
Gordon, C. ;
Boumpas, D. T. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) :195-205
[6]   The MutT proteins or ''nudix'' hydrolases, a family of versatile, widely distributed, ''housecleaning'' enzymes [J].
Bessman, MJ ;
Frick, DN ;
OHandley, SF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (41) :25059-25062
[7]   Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism [J].
Boonsrirat, U. ;
Angsuthum, S. ;
Vannaprasaht, S. ;
Konapurivijit, J. ;
Hirankarn, N. ;
Tassaneeyakul, W. ;
Avihingsanon, Y. .
LUPUS, 2008, 17 (02) :132-134
[8]   Thiopurine Methyltransferase Gene Polymorphisms in Chinese Patients with Inflammatory Bowel Disease [J].
Cao, Qian ;
Zhu, Qin ;
Shang, Yan ;
Gao, Min ;
Si, Jianmin .
DIGESTION, 2009, 79 (01) :58-63
[9]   Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2 [J].
Carter, Megan ;
Jemth, Ann-Sofie ;
Hagenkort, Anna ;
Page, Brent D. G. ;
Gustafsson, Robert ;
Griese, Julia J. ;
Gad, Helge ;
Valerie, Nicholas C. K. ;
Desroses, Matthieu ;
Bostrom, Johan ;
Berglund, Ulrika Warpman ;
Helleday, Thomas ;
Stenmark, Pal .
NATURE COMMUNICATIONS, 2015, 6
[10]   NUDT15 c.415C>T increases risk of 6-mercaptopurine induced myelosuppression during maintenance therapy in children with acute lymphoblastic leukemia [J].
Chiengthong, Kanhatai ;
Ittiwut, Chupong ;
Muensri, Sasipa ;
Sophonphan, Jiratchaya ;
Sosothikul, Darintr ;
Seksan, Panya ;
Suppipat, Koramit ;
Suphapeetiporn, Kanya ;
Shotelersuk, Vorasuk .
HAEMATOLOGICA, 2016, 101 (01) :E24-E26